Web Analytics

3 Latest Announced Rounds

  • $13,000,000
    Unknown

    3 Investors

    Biotechnology Research
    Dec 12th, 2025
  • $4,000,000
    Pre-Seed

    2 Investors

    Technology, Information and Internet
    Dec 12th, 2025
  • $3,800,000
    Seed

    3 Investors

    Technology, Information and Internet
    Dec 12th, 2025
$698.02M Raised in 47 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Phialogics - The immune tolerance company

start up
Germany - Frankfurt, Hesse
  • 08/05/2023
  • Pre-Seed
  • $662,970

Our immune checkpoint activators protect patient’s organ tissue.
Unique approach :
- Potential for BEST-in-class super agonist against immune-mediated tissue damage
- High selectivity for active T-cells
- Proof of concept in relevant human in vitro models and mouse model of disease


Related People

Andreas ErnstFounder

Andreas Ernst Germany - ND

Expert in protein engineering with a keen interest in drug development for the treatment of autoimmune diseases.